Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea

• मुख्य लेखकों: Nam-Jun Cho (लेखक), Dae-Yeon Kim (लेखक), Soon Hyo Kwon (लेखक), Tae Won Ha (लेखक), Hyun Kyu Kim (लेखक), Man Ryul Lee (लेखक), Sung Wan Chun (लेखक), Samel Park (लेखक), Eun-young Lee (लेखक), Hyo-Wook Gil (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: The Korean Society of Nephrology, 2021-09-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background Dipeptidyl peptidase-4 (DPP-4) inhibitor has been reported to have kidney-protective benefits. To elucidate how antidiabetic agents prevent diabetic kidney disease progression, it is important to investigate their effect on the kidney environment in type 2 diabetes mellitus (DM) patients....